LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells

Musculoskeletal Research Group

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Autoimmune pathologies are caused by a breakdown in self-tolerance. Tolerogenic dendritic cells (tolDC) are a promising immunotherapeutic tool for restoring self-tolerance in an antigen-specific manner. Studies about tolDC have focused largely on generating stable maturation-resistant DC, but few have fully addressed questions about the antigen-presenting and migratory capacities of these cells, prerequisites for successful immunotherapy. Here, we investigated whether human tolDC, generated with dexamethasone and the active form of vitamin D3, maintained their tolerogenic function upon activation with LPS (LPS-tolDC), while acquiring the ability to present exogenous autoantigen and to migrate in response to the CCR7 ligand CCL19. LPS activation led to important changes in the tolDC phenotype and function. LPS-tolDC, but not tolDC, expressed the chemokine receptor CCR7 and migrated in response to CCL19. Furthermore, LPS-tolDC were superior to tolDC in their ability to present type II collagen, a candidate autoantigen in rheumatoid arthritis. tolDC and LPS-tolDC had low stimulatory capacity for allogeneic, naive T cells and skewed T cell polarization toward an anti-inflammatory phenotype, although LPS-tolDC induced significantly higher levels of IL-10 production by T cells. Our finding that LPS activation is essential for inducing migratory and antigen-presenting activity in tolDC is important for optimizing their therapeutic potential. J. Leukoc. Biol. 85: 243-250; 2009.

Original languageEnglish
Pages (from-to)243-250
Number of pages8
JournalJournal of Leukocyte Biology
Volume85
Issue number2
Early online date6 Nov 2008
DOIs
Publication statusPublished - 1 Feb 2009

Keywords

  • tolerance
  • migration
  • CCR7
  • naive T cells
  • immunotherapy
  • cardiac allograft survival
  • collagen-induced arthritis
  • regulatory T-cells
  • immune deviaton
  • in-vivo
  • inflammatory stimuli
  • RNA interference
  • express IL-4
  • II collagen
  • tolerance
  • migration
  • CCR7
  • naïve T cells

Cite this

LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. / Musculoskeletal Research Group.

In: Journal of Leukocyte Biology, Vol. 85, No. 2, 01.02.2009, p. 243-250.

Research output: Contribution to journalArticle

@article{519013d7426446efbe8e3e9aee1aa4e1,
title = "LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells",
abstract = "Autoimmune pathologies are caused by a breakdown in self-tolerance. Tolerogenic dendritic cells (tolDC) are a promising immunotherapeutic tool for restoring self-tolerance in an antigen-specific manner. Studies about tolDC have focused largely on generating stable maturation-resistant DC, but few have fully addressed questions about the antigen-presenting and migratory capacities of these cells, prerequisites for successful immunotherapy. Here, we investigated whether human tolDC, generated with dexamethasone and the active form of vitamin D3, maintained their tolerogenic function upon activation with LPS (LPS-tolDC), while acquiring the ability to present exogenous autoantigen and to migrate in response to the CCR7 ligand CCL19. LPS activation led to important changes in the tolDC phenotype and function. LPS-tolDC, but not tolDC, expressed the chemokine receptor CCR7 and migrated in response to CCL19. Furthermore, LPS-tolDC were superior to tolDC in their ability to present type II collagen, a candidate autoantigen in rheumatoid arthritis. tolDC and LPS-tolDC had low stimulatory capacity for allogeneic, naive T cells and skewed T cell polarization toward an anti-inflammatory phenotype, although LPS-tolDC induced significantly higher levels of IL-10 production by T cells. Our finding that LPS activation is essential for inducing migratory and antigen-presenting activity in tolDC is important for optimizing their therapeutic potential. J. Leukoc. Biol. 85: 243-250; 2009.",
keywords = "tolerance, migration, CCR7, naive T cells, immunotherapy, cardiac allograft survival, collagen-induced arthritis , regulatory T-cells, immune deviaton, in-vivo, inflammatory stimuli, RNA interference, express IL-4, II collagen, tolerance , migration , CCR7 , na{\"i}ve T cells",
author = "Anderson, {Amy Nancy} and Swan, {David J} and Sayers, {Bethan L.} and Harry, {Rachel A.} and Patterson, {Angela Margaret} and {von Delwig}, Alexei and J. Robinson and Isaacs, {John D.} and Hilkens, {Catharien M. U.} and {Musculoskeletal Research Group}",
year = "2009",
month = "2",
day = "1",
doi = "10.1189/jlb.0608374",
language = "English",
volume = "85",
pages = "243--250",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "2",

}

TY - JOUR

T1 - LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells

AU - Anderson, Amy Nancy

AU - Swan, David J

AU - Sayers, Bethan L.

AU - Harry, Rachel A.

AU - Patterson, Angela Margaret

AU - von Delwig, Alexei

AU - Robinson, J.

AU - Isaacs, John D.

AU - Hilkens, Catharien M. U.

AU - Musculoskeletal Research Group

PY - 2009/2/1

Y1 - 2009/2/1

N2 - Autoimmune pathologies are caused by a breakdown in self-tolerance. Tolerogenic dendritic cells (tolDC) are a promising immunotherapeutic tool for restoring self-tolerance in an antigen-specific manner. Studies about tolDC have focused largely on generating stable maturation-resistant DC, but few have fully addressed questions about the antigen-presenting and migratory capacities of these cells, prerequisites for successful immunotherapy. Here, we investigated whether human tolDC, generated with dexamethasone and the active form of vitamin D3, maintained their tolerogenic function upon activation with LPS (LPS-tolDC), while acquiring the ability to present exogenous autoantigen and to migrate in response to the CCR7 ligand CCL19. LPS activation led to important changes in the tolDC phenotype and function. LPS-tolDC, but not tolDC, expressed the chemokine receptor CCR7 and migrated in response to CCL19. Furthermore, LPS-tolDC were superior to tolDC in their ability to present type II collagen, a candidate autoantigen in rheumatoid arthritis. tolDC and LPS-tolDC had low stimulatory capacity for allogeneic, naive T cells and skewed T cell polarization toward an anti-inflammatory phenotype, although LPS-tolDC induced significantly higher levels of IL-10 production by T cells. Our finding that LPS activation is essential for inducing migratory and antigen-presenting activity in tolDC is important for optimizing their therapeutic potential. J. Leukoc. Biol. 85: 243-250; 2009.

AB - Autoimmune pathologies are caused by a breakdown in self-tolerance. Tolerogenic dendritic cells (tolDC) are a promising immunotherapeutic tool for restoring self-tolerance in an antigen-specific manner. Studies about tolDC have focused largely on generating stable maturation-resistant DC, but few have fully addressed questions about the antigen-presenting and migratory capacities of these cells, prerequisites for successful immunotherapy. Here, we investigated whether human tolDC, generated with dexamethasone and the active form of vitamin D3, maintained their tolerogenic function upon activation with LPS (LPS-tolDC), while acquiring the ability to present exogenous autoantigen and to migrate in response to the CCR7 ligand CCL19. LPS activation led to important changes in the tolDC phenotype and function. LPS-tolDC, but not tolDC, expressed the chemokine receptor CCR7 and migrated in response to CCL19. Furthermore, LPS-tolDC were superior to tolDC in their ability to present type II collagen, a candidate autoantigen in rheumatoid arthritis. tolDC and LPS-tolDC had low stimulatory capacity for allogeneic, naive T cells and skewed T cell polarization toward an anti-inflammatory phenotype, although LPS-tolDC induced significantly higher levels of IL-10 production by T cells. Our finding that LPS activation is essential for inducing migratory and antigen-presenting activity in tolDC is important for optimizing their therapeutic potential. J. Leukoc. Biol. 85: 243-250; 2009.

KW - tolerance

KW - migration

KW - CCR7

KW - naive T cells

KW - immunotherapy

KW - cardiac allograft survival

KW - collagen-induced arthritis

KW - regulatory T-cells

KW - immune deviaton

KW - in-vivo

KW - inflammatory stimuli

KW - RNA interference

KW - express IL-4

KW - II collagen

KW - tolerance

KW - migration

KW - CCR7

KW - naïve T cells

U2 - 10.1189/jlb.0608374

DO - 10.1189/jlb.0608374

M3 - Article

VL - 85

SP - 243

EP - 250

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 2

ER -